Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/2013
Title: Results of a combination of bleomycin and triamcinolone acetonide in the treatment of keloids and hypertrophic scars.
Authors: Camacho-Martínez, Francisco Miguel
Rodríguez Rey, Elena
Camacho Serrano, Francisco
Wagner, Adriana
metadata.dc.contributor.authoraffiliation: [Camacho-Martínez,FM; Rodríguez Rey,E] Department of Dermatology and Venereology Virgen Macarena University Hospital, Seville, Spain. [Camacho Serrano,F] General Surgical Department, Virgen Macarena University Hospital, Seville, Spain. [Wagner,A] Department of Dermatology, Imbanaco Medical Center, Cali, Colombia.
Keywords: Bleomycin;Keloid;Triamcinolone acetonide;Antibióticos antineoplásicos;Bleomicina;Queloide;Acetónido de triamcinolona;Cicatriz hipertrófica
metadata.dc.subject.mesh: Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antirheumatic Agents::Anti-Inflammatory Agents, Non-Steroidal
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antibiotics, Antineoplastic
Medical Subject Headings::Chemicals and Drugs::Carbohydrates::Glycoconjugates::Glycopeptides::Bleomycin
Medical Subject Headings::Anatomy::Tissues::Connective Tissue::Granulation Tissue::Cicatrix::Cicatrix, Hypertrophic
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy, Combination
Medical Subject Headings::Check Tags::Female
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Follow-Up Studies
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Routes::Injections::Injections, Intralesional
Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Fibrosis::Cicatrix::Keloid
Medical Subject Headings::Check Tags::Male
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Photography
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Physical Examination::Pigmentation::Skin Pigmentation
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome
Medical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Steroids::Pregnanes::Pregnadienes::Triamcinolone::Triamcinolone Acetonide
Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Young Adult
Medical Subject Headings::Named Groups::Persons::Age Groups::Adult
Issue Date: May-2013
Publisher: Sociedade Brasileira de Dermatologia
Citation: Camacho-Martínez FM, Rodríguez Rey E, Camacho Serrano F, Wagner A. Results of a combination of bleomycin and triamcinolone acetonide in the treatment of keloids and hypertrophic scars. An Bras Dermatol. 2013; 88(3):387-94
Abstract: While treatment of keloids and hypertrophic scars normally shows modest results, we found that treatment with bleomycin was more promising. The present study was divided into two parts. In the first part the aim was to show the results using a combination of bleomycin and triamcinolone acetonide per cm2 (BTA). In the second part the objective was to determine the response to both drugs in large keloids that were divided into 1 cm2 squares, treating each square with the dose previously used. In the first part of the study, the clinical response of 37 keloids ranging from 0.3 to 1.8 cm2 treated with BTA were followed up over a period of 1- 2 years. 0.375 IU bleomycin and 4 mg triamcinolone acetonide were injected every 3 months. In the second part of the study we reviewed the clinical response in six patients with large keloids. The monthly dose administered never exceeded 3 IU of bleomycin. The first study showed 36 keloids (97.29%) softening after the first dose. In the second study, 5 showed different responses (the response was complete in the four smaller keloids). The largest keloid needed 9 doses to achieve an improvement of 70%. In conclusion, combined treatment with 0.375 IU of bleomycin and 4mg of triamcinolone acetonide to 1 cm2 was considered to be an acceptable procedure for the treatment of keloids. The best results were obtained in keloids over 1 cm2 or when divided into 1 cm2 square areas. Larger series need to be performed in order to confirm these results..
Description: Journal Article;
URI: http://hdl.handle.net/10668/2013
metadata.dc.relation.publisherversion: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962013000300387&lng=en&nrm=iso&tlng=en
metadata.dc.identifier.doi: 10.1590/abd1806-4841.20131802
ISSN: 1806-4841 (Online)
0365-0596 (Print)
Appears in Collections:01- Artículos - Hospital Virgen Macarena

Files in This Item:
File Description SizeFormat 
Camacho-Martínez_ResultsCombinationBleomycin.pdfRevisión353,64 kBAdobe PDFView/Open


This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons